New hope for pancreatic cancer: targeted drug plus chemo enters trials
Disease control
Not yet recruiting
This study tests a new drug called ANO31905 combined with standard chemotherapy as a first treatment for people with a specific type of advanced pancreatic cancer (CLDN18.2-positive). About 84 adults with cancer that cannot be removed by surgery or has spread will take part. The …
Phase: PHASE1, PHASE2 • Sponsor: Anova Innovation Limited • Aim: Disease control
Last updated May 17, 2026 07:06 UTC